Cite

HARVARD Citation

    At Thobari, J. et al. (2021). Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial. Vaccine. 39 (33), pp. 4651-4658. [Online]. 
  
Back to record